Equitec Proprietary Markets, LLC Oyster Point Pharma, Inc. Put Options Transaction History

Equitec Proprietary Markets, LLC

  • $92.9 Million
  • Q3 2024

Put Options

1 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q4 2022

Jan 31, 2023
BUY
$7.95 - $11.68 $221,010 - $324,704
27,800 New
27,800 $310,000

Others Institutions Holding OYST

# of Institutions
4
Shares Held
19K
Call Options Held
0
Put Options Held
0
View Full List

About Oyster Point Pharma, Inc.

OYST Quotes by TradingView
  • Ticker OYST
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,831,500
  • Description
  • Oyster Point Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical therapies to treat ophthalmic diseases in the United States. The company's product candidate is TYRVAYA, a nicotinic acetylcholine receptor agonist for the treatment of signs and symptoms of dry ...
More about OYST
Track This Portfolio

Track Equitec Proprietary Markets, LLC Portfolio

Follow Equitec Proprietary Markets, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Equitec Proprietary Markets, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Equitec Proprietary Markets, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email